期刊文献+

可透过血脑屏障的MRI造影剂的实验研究 被引量:2

An empirical study on MRI contrast agents passing through the blood brain barrier
下载PDF
导出
摘要 目的探索开发一种可透过血脑屏障的MRI造影剂,为进一步开发靶向脑内的特异性分子探针打下基础。方法用聚山梨酯80包被Fe3O4纳米颗粒制成注射液,注入20只新西兰兔耳背静脉内。结果注入造影剂后第5、10、30分钟行MR扫描,20只实验兔T2WI脑实质信号随着时间延长而逐渐降低,12 h后行MR扫描,信号显著降低。结论聚山梨酯80包被的Fe3O4纳米颗粒,是一种理想的穿透血脑屏障的MRI造影剂,可用于靶向脑内的分子探针的开发。 Objective To develop a kind of contrast agent which can pass through blood brain barrier for MRI use, and to form a base to further develop the special targeted inner-brain molecular probe. Methods The mixture of Fe3O4 nanoparticles packed by polysorbate80 was inject- ed into 20 New Zealand rabbits. Results MRI scanning was carried out 5 min, 10 min and 30 min after the injection. The T2WI showed that the signal of the brain essence of the 20 rabbits dropped gradually with time passing by. And 12 hours later, the signal dropped significantly. Conclusion Fe3O4 nanoparticles packed by polysorbate 80 is an ideal and practical contrast agent which can pass through blood brain barrier for MRI use. This contrast agent can be used to develop the targeted in- ner-brain molecular probes.
出处 《实用临床医药杂志》 CAS 2012年第19期167-168,170,共3页 Journal of Clinical Medicine in Practice
基金 南京市医学科技发展基金资助课题(YKK08144)
关键词 分子探针 聚山梨酯 磁共振成像 造影剂 molecular probe polysorbate magnetic resonance imaging contrast agents
  • 相关文献

参考文献5

  • 1Weissleder R. Molecular imaging: exploring the next frontier [J].Radiology, 1999, 212: 609.
  • 2张龙江,祁吉.分子影像学探针的研究与进展[J].国外医学(临床放射学分册),2006,29(5):289-293. 被引量:14
  • 3陆菁菁,王芳,金征宇,钟定荣.靶向磁性纳米粒子用于肿瘤的磁共振分子成像[J].中国医学科学院学报,2009,31(2):124-128. 被引量:8
  • 4Fenart L, Casanova A, Dehouck B, et al. Effects of apolipoproteins on dalargin transport across the blood brain barrier[J ]. Bulletin of Experimental Biology and Medicine, 2006, 6: 703.
  • 5Kreuter J. Nanoparticulate system for brain delivery of drugs [J]. Adv Drug Deliv Rev, 2001, 1: 65.

二级参考文献32

  • 1Weissleder R. Molecular imaging : exploring the next frontier [J]. Radiology, 1999, 212(3) :609-614.
  • 2Weissleder R, Pittet MJ. Imaging in the era of molecular oncology [J]. Nature, 2008, 452(7187) :580-589.
  • 3Hu FQ, Wei L, Zhou Z, et al. Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer [ J]. Adv Mater, 2006, 18 (19) : 2553- 2556.
  • 4Li Z, Wei L, Gao MY, et al. One-pot reaction to synthesize biocompatible magnetite nanoparticles [ J]. Adv Mater, 2005, 17 ( 8 ) : 1002-1005.
  • 5Weissleder R, Mahmood U. Molecular imaging [J]. Radiology, 2001, 219(2) :316-333.
  • 6McCarthy J, Weissleder R. Multifuncfional magnetic nanoparticles for targeted imaging and therapy [ J]. Adv Drug Deliv Rev, 2008, 60(11) :1241-1251.
  • 7Mulder W, Schaft D, Hautvast P, et al. Early in vivo assessment of angiostatic therapy efficacy by molecular MRI [J]. FASEB J, 2007, 21(2) :378-383.
  • 8Beckman R, Weiner L, Davis H. Antibody constructs in cancer therapy [J]. Cancer, 2007, 109(2) :170-179.
  • 9Jain M, Venkatraman G, Batra S. Optimization of radioimmunotherapy of solid tumors: biological impediments and their modulation [ J ]. Clin Cancer Res, 2007, 13 ( 5 ) : 1374-1382.
  • 10Greish K. Enhanced permeability and retention of maeromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines[J].J Drug Target, 2007, 15 (7- 8 ) :457-464.

共引文献19

同被引文献43

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部